Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Issued
Ratios

X4 Pharmaceuticals (XFOR) Leases (2019 - 2025)

X4 Pharmaceuticals' Leases history spans 7 years, with the latest figure at $1.4 million for Q4 2025.

  • For Q4 2025, Leases fell 65.34% year-over-year to $1.4 million; the TTM value through Dec 2025 reached $1.4 million, down 65.34%, while the annual FY2025 figure was $1.4 million, 65.34% down from the prior year.
  • Leases reached $1.4 million in Q4 2025 per XFOR's latest filing, down from $1.8 million in the prior quarter.
  • In the past five years, Leases ranged from a high of $9.8 million in Q1 2021 to a low of $1.4 million in Q4 2025.
  • Average Leases over 5 years is $6.1 million, with a median of $6.3 million recorded in 2023.
  • Peak YoY movement for Leases: soared 473.6% in 2021, then crashed 65.34% in 2025.
  • A 5-year view of Leases shows it stood at $8.7 million in 2021, then dropped by 17.0% to $7.2 million in 2022, then fell by 21.84% to $5.6 million in 2023, then fell by 28.05% to $4.1 million in 2024, then plummeted by 65.34% to $1.4 million in 2025.
  • Per Business Quant, the three most recent readings for XFOR's Leases are $1.4 million (Q4 2025), $1.8 million (Q3 2025), and $2.6 million (Q2 2025).